Joseph Hargett

Joseph Hargett

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street JournalThe New York TimesMoney Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

Thursday’s Vital Data: Facebook Inc (FB), Alibaba Group Holdings Ltd (BABA) and Gilead Sciences, Inc. (GILD)

Facebook (FB) plunges on ad revenue concerns, Alibaba Group (BABA) options mixed on 2Q earnings and Gilead Sciences (GILD) misses earnings.

GoPro Inc (GPRO) Stock Looking For a Hero

Beaten down GPRO stock looks to Hero 5 and Karma for guidance boost as GoPro third-quarter earnings are set to decline year over year.

Wednesday’s Vital Data: Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) and Bank of America Corp (BAC)

Apple (AAPL) pulls trendlines into bear cross, Valeant (VRX) bounces on potential Salix sale and Bank of America (BAC) options await Fed.

Bank of America Corp (BAC) Stock Will Fight On After the FOMC

Bank of America (BAC) has seen a nice run since the last FOMC meeting, but BAC stock bulls now need to focus on December.

Tuesday’s Vital Data: Facebook Inc (FB), Alibaba Group Holding Ltd (BABA) and Pfizer Inc. (PFE)

Earnings preparation drives heavy options speculation on Facebook (FB), Alibaba Group (BABA) and Pfizer (PFE).